Unaudited NAV for November 2023 (1795525)
13 December 2023 - 6:00PM
UK Regulatory
Arix Bioscience PLC (ARIX)
Unaudited NAV for November 2023
13-Dec-2023 / 07:00 GMT/BST
=----------------------------------------------------------------------------------------------------------------------
Arix Bioscience plc
Unaudited NAV for November 2023
LONDON, 13 December 2023: Arix Bioscience plc ("Arix" or the "Company") (LSE: ARIX), a transatlantic venture capital
company focused on investing in breakthrough biotechnology companies, announces the unaudited estimated Net Asset Value
("NAV") of the Company for the date ended 30 November 2023 as follows:
NAV Breakdown
Date Total NAV
Listed Portfolio Unlisted Portfolio Cash Other Interests NAV per share
30 November 2023
GBP54.3m GBP66.4m GBP105.8m GBP2.6m GBP229.1m GBP1.77
(unaudited)
[ENDS]
Enquiries
For more information on Arix, please contact:
Arix Bioscience plc
+44 (0)20 7290 1050
ir@arixbioscience.com
Powerscourt
Sarah MacLeod, Nick Johnson, Molly Ring
+44 (0)20 7250 1446
arix@powerscourt-group.com
About Arix Bioscience plc
Arix Bioscience plc is a transatlantic venture capital company
focused on investing in breakthrough biotechnology companies around
cutting-edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the
capital, expertise, and global networks to help accelerate their
ideas into important new treatments for patients. As a listed
company, we are able to bring this exciting growth phase of our
industry to a broader range of investors.
www.arixbioscience.com
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Regulatory Announcement, transmitted by EQS
Group. The issuer is solely responsible for the content of this
announcement.
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071
Category Code: MSCM
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 291541
EQS News ID: 1795525
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1795525&application_name=news
(END) Dow Jones Newswires
December 13, 2023 02:00 ET (07:00 GMT)
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Dec 2023 to Dec 2024